Objective: Gamma-hydroxybutyrate (GHB) is an endogenous GHB-/GABA-B receptor agonist and a narcolepsy treatment. However, GHB is also abused for its prohedonic effects. On a neuronal level, it was shown that GHB increases regional cerebral blood flow in limbic areas such as the right anterior insula (rAI) and the anterior cingulate cortex (ACC). We aimed to further explore the association between the subjective and neuronal signatures of GHB.
has strong downstream neuromodulatory effects also on glutamate, dopamine, serotonin, norepinephrine, and cholinergic transmission (Andresen, Aydin, Mueller, & Iwersen-Bergmann, 2011) .
As a medical drug, GHB is used for the treatment of neuropsychiatric disorders such as narcolepsy (Boscolo-Berto et al., 2012) , alcohol withdrawal and relapse prevention (Leone, VignaTaglianti, Avanzi, Brambilla, & Faggiano, 2010) , and fibromyalgia (Spaeth et al., 2013) . Because of its unique pharmacological profile including mood enhancing, prosocial, and prosexual effects the drug was also proposed as an experimental therapeutic in depression, especially with pronounced anhedonia (Bosch, Quednow, Seifritz, & Wetter, 2012; Bosch & Seifritz, 2016; Mamelak, 2009) , which is an important target of antidepressant treatment (Argyropoulos & Nutt, 2013) . However, for the same prohedonic effects, the drug is also a drug of abuse (Miotto et al., 2001; Sumnall, Woolfall, Edwards, Cole, & Beynon, 2008) . In fact, although prosexual effects of GHB are not among the most frequent side effects such as sedation, nausea, dizziness, and headaches, in clinical populations (Alshaikh, Gacuan, George, Sharif, & Bahammam, 2011; Leone et al., 2010; Spaeth et al., 2013) , they are regularly reported in the context of illicit use (KapitanyFoveny et al., 2015 , Miotto et al., 2001 , Sumnall et al., 2008 . As such, GHB is a very well-known substance among club drugs, as recently reported in different studies in samples of adolescents and young adults (Martinotti et al., 2015; Martinotti et al., 2017) . In this population, GHB is frequently used in combination with other drugs such as alcohol, stimulants, and cannabis, which leads to more severe clinical intoxication features and more frequent need of acute medical treatment (Miro et al., 2017) . The drug has an addictive potential that seems to strongly vary (0.04%-21%) by the setting in which the drug is applied (medication vs. illicit use; Carter, Pardi, Gorsline, & Griffiths, 2009; Leone et al., 2010) .
Although GHB was developed already 1960 by Henri Laborit (Kunz, 2014; Laborit, Buchard, Laborit, Kind, & Weber, 1960) , investigation of its neuronal effects using neuroimaging techniques started only recently. Here, we performed an experimental study on the subjective and neuronal effects of 35 mg/kg GHB p.o. in 20 healthy male participants. Due to the variety of used methods, produced results and covered topics, the investigation is described across four papers, focusing on task-related brain reactivity towards sexual stimulation , whole-brain resting-state cerebral perfusion and body and emotion awareness (Bosch, Esposito et al., 2017) , whole-brain resting-state functional connectivity and vigilance effects (sedation and stimulation; Bosch et al., 2018) , as well as a seed-based analysis of the two most important GHBrelated brain areas (right anterior insula [rAI] and anterior cingulate cortex (ACC) and prohedonic effects (euphoria and sexual arousal), which we present here. We found that under influence of the drug, even sexually neutral pictures elicited sexual arousal and activated the bilateral nucleus accumbens (NAcc) and right ACC . Additionally, a psychophysiological interaction analysis revealed increased task-related functional connectivity between NAcc and ventromedial prefrontal cortex (vmPFC) during processing of erotic pictures under GHB, the condition in which subjective sexual arousal was highest . In a second analysis of the same sample, GHB increased body and emotion awareness and regional cerebral blood flow (rCBF) in limbic areas such as the rAI and the bilateral ACC, which correlated with each other (Bosch, Esposito, et al., 2017) . Moreover, a further resting-state functional connectivity (rsFC) analysis of these data showed that GHB increases salience network rsFC to the default mode network and dorsomedial prefrontal cortex (dmPFC) and from there reciprocally to the salience network (rIA) and to the central executive network (right middle frontal gyrus [MFG] ). In this analysis, increased sedation significantly predicted the observed increase in rAI-dmPFC-rsFC . Hence, first neuroimaging data in humans demonstrate GHB's activating effects on salience, reward, and central executive networks, with a key role for the rAI and the ACC.
To further explore the relationship between the neuronal signature on these structures and the prohedonic effects of the drug, we assessed hedonic subjective effects of GHB (35 mg/kg p.o.) including euphoria and sexual arousal (together with the typical side effect nausea), and the rsFC of the above mentioned rAI-and ACC-seeding points (Bosch, Esposito, et al., 2017) in a sample of 19 healthy male subjects that has been used for previous analyses Bosch, Esposito, et al., 2017) . Similarities to the previous publications are the same study and sample. However, we did not use the results of previous functional connectivity analyses to guide any of the choices made for the new functional connectivity analysis. This was particularly the case for the selection of the rAI and ACC seed regions in the seed-based functional connectivity analysis, which were not derived from the network-based independent component analysis (ICA) shown in the previous report . In fact, ICA extracts intrinsic functional connectivity networks from the data without the need of a priori regions of interest (ROIs). In contrast to previous reports, here, we specifically targeted the whole-brain functional connectivity from a priori ROIs, which we had found hyper perfused by the GHB challenge using a different and completely independent data set acquired using ASL-MRI (Bosch, Esposito, et al., 2017) . As we did not use the same data to define the seed ROIs and then to trace the connectivity, our results are free of the so called "double dip"
issue (see, e. g., (Kriegeskorte, Simmons, Bellgowan, & Baker, 2009) , that is, we are not overfitting the data. We used a placebocontrolled, double-blind, randomized, cross-over functional magnet resonance imaging (fMRI) design with 4-time points for rsFC assessment (baseline and 34, 59, and 79 min post GHB intake) and hypothesized that GHB would alter rAI-and ACC-rsFC. Moreover, we expected that changes in limbic rsFC are correlated with the hedonic subjective effects of the drug. ±18.4, 88-145) , and a mean weight of 72.2 kg (±7.4, 59-85 kg).
Subjects were recruited by online advertisings and underwent a medical and psychiatric examination applying the Structured Clinical Interview for DSM-IV Axis-I Disorders (First, Spitzer, Gibbon, & Williams, 2002) . Exclusion criteria were any DSM-IV psychiatric disorder, neurological disorder, severe medical disease, left handedness, and regular illegal drug use (lifetime use on five and more occasions, with exception of occasional cannabis use), the latter was assessed by using the Interview for Psychotropic Drug Consumption (Quednow, Kuhn, Hoenig, Maier, & Wagner, 2004) . Participants performed a German vocabulary test, the MehrfachwahlWortschatz-Intelligenztest (Lehrl, 2005) , to estimate the verbal intelligence quotient. They had to abstain from drinking alcohol 24 hr before the experimental sessions and from drinking caffeinated beverages during the course of the study days. Abstinence from illegal drugs at the test sessions was ensured by semiquantitative drug urine tests (Dimension RXL Max, Siemens, Erlangen, Germany). The study was approved by the Cantonal Ethics Committee of Zurich and by Swissmedic and was registered at ClinicalTrials.gov (NCT02342366).
All participants gave written informed consent and were financially compensated.
| Procedure
GHB and placebo were applied in two sessions separated by 7 days.
On both test days, participants completed an fMRI paradigm ) on a Philips Achieva 3Tesla whole-body MR-unit equipped with a 32-channel receive head coil (Philips Medical Systems, Best, The Netherlands). The experiment started with a T1-weighted anatomical brain scan, a baseline rsFC scan, and an arterial spin labeling (ASL) scan. Subsequently, participants were taken out of the scanner and were orally administered a single dose of GHB (35 mg/kg) or placebo (t = 0 min). As C max of GHB can be expected after about 40 min (Liechti et al., 2016) , the fMRI paradigm began at t + 30 min. Then, the procedure of scans was as follows: rsFC (34 min), ASL, task scan, rsFC (59 min), ASL, task scan, rsFC (79 min), ASL. Subjective drug effects were assessed using visual analogue scales (VAS; 100 mm scale, with item name and according statement, for example, "I feel euphoric" for euphoria, with "not at all" and "strongly" on the poles of the scale, selection via hand tool with scroll function inside the scanner, between scans) on general drug effect, sedation, relaxation, stimulation, euphoria, body awareness, emotion awareness, sexual arousal, dizziness, and nausea. VAS scales were applied at time points t = −25 min before and 45, 55, 68, 77, and 93 min after drug/placebo administration. Experimental sessions lasted 200 min. Here, the GHB effects on euphoria, sexual arousal, and nausea as well as rsFC data of the rAI-and ACC-seed analyses are presented, whereas other fMRI data have been published elsewhere Bosch, Esposito, et al., 2017; . In detail, all VAS scores have been published as follows: general drug effect, sedation and stimulation , relaxation (Bosch, Esposito, et al., 2017) , subjective effects in reaction to the sexual stimulation task , body awareness, emotion awareness, dizziness (Bosch, Esposito, et al., 2017) , sexual arousal, euphoria, and nausea (present manuscript).
| MRI data acquisition
The rsFC time series were acquired with a sensitivity-encoded single- 
| MRI data preprocessing
Standard image data preparation and preprocessing, as well as statistical analysis and visualization were performed with the software BrainVoyager QX (Brain Innovation BV, The Netherlands). Functional data preprocessing included a correction for slice scan timing acquisition, a 3-dimensional rigid body motion correction, a spatial smoothing (gaussian kernel of 6 mm full-width-half-maximum), a temporal high-pass filter with cutoff set to 0.008 Hz per time-course and a temporal low-pass filter (Gaussian kernel of 3 s).
Structural and functional data were coregistered and spatially normalized to the Talairach standard space using a 12-parameter affine transformation. In the course of this procedure, the functional images were resampled to an isometric 3 × 3 × 3 mm 3 grid covering the entire Talairach box. Nuisance signals (white matter and cerebro-spinal fluid signals) were regressed out from each data set together with motion translation and rotation estimates after segmenting the entire brain, the white matter and ventricles from the normalized T1 volume.
A seed-based analysis was performed to study rsFC from the rAI, and the ACC according to GHB-induced rCBF increases in a previous study (Bosch, Esposito, et al., 2017) . To compute rsFC maps corresponding to a selected seed region of interest (ROI), the mean regional time course was extracted from all ROI voxels and correlated against all voxels of the brain. The definition of two ROIs was based on our previous work (Bosch, Esposito, et al., 2017) , and separate correlation maps were produced for each subject, condition, and ROI. The correlation maps were applied the Fisher's r-to-z transform
) before entering the second-level randomeffects statistical analysis.
| Statistical analysis of VAS data
For the analyses of VAS scales, repeated measures analyses of variance (ANOVA) with drug (2-fold: GHB, placebo) and time (6-fold)
as within-subject factors were applied using SPSS®22.0 for Windows.
Greenhouse-Geisser correction and adjusted p values were used in models with more than one degree of freedom in the numerator.
Bonferroni-corrected paired t tests were applied for post hoc treatment comparisons (placebo vs. GHB, 6-time points). All confirmatory statistical comparisons were carried out at a significance level of p < 0.05 (two tailed).
| Statistical analysis of MR images
For the whole-brain voxel-based rsFC analysis, all Talairachnormalized rsFC z maps from the preprocessed 144 rsfMRI data sets (18 subjects [one subject was excluded from these analyses due to missing data in one of the sessions], 2 sessions, 4 repeated scans) were combined and entered into the analysis of covariance (ANCOVA) module of BrainVoyager QX. Here, a 3-way (4 × 2 × 2) mixed effects ANOVA design was specified with two within-subject factors (scan, treatment) and one between-subject factor (session). Following the experimental design, the factor scan was assigned with four levels (baseline, 34 min, 59 min, 79 min), the factor treatment with two levels (GHB, placebo), and the factor session had two levels (GHB-first, placebo-first). All interactions between and among all three factors were also added to the model. After least square model fitting, to detect any effects of systematic rsFC changes in relation to time, treatment, and session, the F statistics for the 3-way interaction (scan x treatment x session) was computed at each voxel, yielding a whole-brain F-map, which was overlaid in pseudo-color onto the average normalized T1 image.
To protect against false positives and correct for multiple comparisons, only statistically significant regional effects were displayed for compact clusters surviving the joint application of a voxel-level and a cluster-level threshold, which were chosen using a nonparametric randomization approach based on Monte Carlo simulations. Namely, an arbitrary (uncorrected) threshold (p < 0.05) was initially applied to all voxels; then, a minimum cluster size was set in such a way that an average of 5% false positive clusters were counted in 1,000 randomly generated images to which the same thresholds were applied. To match the level of smoothness between the calculated F-map and the simulated images, after random number generation at each voxel, the resulting images were spatially filtered with a Gaussian kernel at the full width at half maximum initially estimated from the data according to (Forman et al., 1995) . Figure 1 ). Of note, the two peaks in sexual arousal at 55 and 77 min FIGURE 1 Effects on visual analogue scale (VAS) scores of GHB versus placebo for euphoria, sexual arousal, and nausea. ***p < 0.001, **p < 0.01, *p < 0.05 (Bonferroni corrected) after intake ( Figure 1b) are explained by the fMRI task that was presented before, in which erotic pictures were shown .
| Neuroimaging
We performed a seed-based analysis for possible 3-way interaction effects in a voxel-based 3-way ANOVA analysis with factors scan (baseline, 34, 59, 79 min after intake), treatment (GHB, placebo), session (GHB first, placebo first), using the rAI as well as the ACC according to a previous study (Bosch, Esposito, et al., 2017) . We found a significantly increased rsFC of the rAI seed with the bilateral superior frontal gyrus and with the right thalamus (both p < 0.05, cluster corrected; Figure 2 ). In contrast, ACC-rsFC was decreased to the bilateral paracentral lobule (p < 0.05, cluster corrected; Figure 3 ).
For all significant rsFC, changes in the subjective effects (e.g., 
| DISCUSSION
We investigated the neural effects of the mixed GHB-/GABA-B receptor agonist GHB using rsFC measures of two seeds, namely the rAI and ACC, which were previously shown to exhibit increased rCBF under influence of this drug (Bosch, Esposito, et al., 2017) . The presented results are part of a study described in three other papers Bosch, Esposito, et al., 2017; . We found that in healthy male subjects, 35 mg/kg p.o.
GHB elicits hedonic subjective effects such as euphoria and sexual arousal but not nausea. At the neuronal level, rsFC of the rAI increased to the bilateral superior frontal gyrus and the right thalamus. Moreover, rsFC of the ACC decreased to the bilateral paracentral lobule. Finally, increased rAI-rsFC to the bilateral superior frontal gyrus was correlated with euphoria indicating that the strengthened connectivity between the anterior insula region and the dorsolateral prefrontal cortex might account for the euphorigenic effects of GHB. These results are in accordance with the clinical data in narcolepsy and addiction. However, it is important to emphasize that our results were generated in healthy subjects and that therefore no direct clinical conclusions should be drawn. Kapitany-Foveny et al., 2015; Miotto et al., 2001; Sumnall et al., 2008) . Here, we show that GHB induces euphoria and sexual arousal. Euphoria peaked at 45 min and vanished to placebo level at 77 min post drug intake. On the other hand, for sexual arousal the most significant elevation in the GHB group compared with placebo was observed also at 45 min, with two more significant time points at 68 and 93 min. Quantitatively, there were two peaks at 55 and 77 min due to visual stimulation, were sexual arousal was increased in both the GHB and the placebo group, resulting in no significant difference between the groups.
Both profiles are in line with previous pharmacokinetic and pharmacodynamic studies (Abanades et al., 2006; Bosch et al., 2015; Brenneisen et al., 2004; Liechti et al., 2016) . Depending on dosage and time, GHB frequently exerts biphasic effects such as euphoria in lower doses and in early stages of intoxication and sedation or coma with higher doses and in later stages of intoxication (Abanades et al., 2006; Madah-Amiri, Myrmel, & Brattebo, 2017) .
Although stimulation and euphoria seem to be mediated by a short-lasting disinhibition of thalamocortical neurons and neurons in the VTA via agonism at presynaptic GABA-B receptors, sedative effects involve inhibition of these neurons via post synaptic GABA-B receptors, as well as G protein-gated inwardly rectifying FIGURE 3 Anterior cingulate cortex seed resting state functional connectivity decreases GHB versus placebo: (a) bilateral paracentral lobule, p < 0.05 (cluster corrected) FIGURE 4 Correlation of the euphoria visual analogue scale (VAS) scores and increased resting-state functional connectivity of the right anterior insula with the bilateral superior frontal cortex, GHB versus placebo (p < 0.05, uncorrected) potassium channels, leading to a delayed and more intense neuronal hyperpolarization (Luscher & Slesinger, 2010) .
Euphoria and sexual arousal are frequently reported by illicit users of GHB (Kapitany-Foveny et al., 2015; Sumnall et al., 2008) , but the specificity of these effects is still a matter of debate. These hedonic subjective effects represent the main reasons for the illicit instrumentalization of GHB (Luby, Jones, & Zalewski, 1992; Sumnall et al., 2008) , and they are also proposed as potentially therapeutic features in psychiatric conditions with occurrence of anhedonia (Bosch & Seifritz, 2016) . Both, euphoria and sexual arousal are linked to frontolimbic dopaminergic activity (Drevets et al., 2001; Wise & Bozarth, 1985) , which is dampened in certain anhedonic states (Argyropoulos & Nutt, 2013) . In fact, although most of the subjective and behavioral actions of GHB are mediated by its GABA-B agonism (Carter, Koek, & France, 2009) , its specific hedonic properties such as mood enhancement, as well as prosocial and prosexual activation might be mediated by downstream dopaminergic disinhibition of the VTA via GABAergic autoreceptors on GABAergic interneurons (Bosch et al., 2015; Bosch, Esposito, et al., 2017; Cruz et al., 2004; Labouebe et al., 2007; Maitre, 1997; Pistis et al., 2005) . Although GHB did not induce significant nausea in our volunteers at 35 mg/kg p.o., this is usually a typical side effect of high doses of GHB (Carter, Richards, Mintzer, & Griffiths, 2006; Chin, Kreutzer, & Dyer, 1992; Elsing, Stremmel, Grenda, & Herrmann, 2009; Russell et al., 2011) , which is probably also related to the drug's capacity to rapidly increase central dopaminergic tone. However, the same dose robustly induced dizziness in our participants (Bosch, Esposito, et al., 2017) , which is also a cardinal symptom of GHB intoxication (Bosch & Seifritz, 2016) .
On a neuronal level, we aimed to further explore GHB-induced limbic activation in the rAI and the ACC, as both structures proved to be the core hubs of GHB effects in the human brain, assessed by neuroimaging techniques Bosch, Esposito, et al., 2017; . There is strong evidence from previous neuroimaging studies that the rAI is not only a core hub of the salience network but that it is also selectively activated during the experience of intense positive feelings including interoceptive components (Craig, 2009) . In a positron emission tomography investigation of enhanced mood after physical activity, euphoria was correlated with activity in the rAI and the ACC but also the right superior frontal gyrus (Boecker et al., 2008) , latter of which is the area in which we found a correlation of increased rAI-rsFC and euphoria. Picard, Scavarda, and Bartolomei (2013) demonstrated that direct electrical stimulation of the rAI in an epilepsy patient triggered typical ecstatic auras with an intense feeling of bliss including pleasurable body sensations (Picard et al., 2013) . Using the above mentioned rAI coordinates as seed area for an rsFC analysis, here we found that GHB increases rsFC of the rAI to the bilateral superior frontal gyrus, which is part of the central executive network and the right thalamus. Increased rAI rsFC to the superior frontal gyrus was correlated with euphoria. Consequently, these results add new insights to the significance of the rAI as a core element of the neuronal mediation of GHB effects in humans. Regarding recently discovered rAI-rsFC reductions to the central executive network in major depression (Iwabuchi et al., 2014) , this GHB mechanism might be of high relevance for a biomarker-driven treatment of affective disorders.
The other brain area that showed increased rAI-rsFC in our sample was the right anterior thalamus. It is well-known that the thalamus has an important bottom-up gating and regulating function on cortical activity (Cappe, Rouiller, & Barone, 2012) and contributes to the salience and the reward networks (Cho et al., 2013; Menon, 2015; Menon & Uddin, 2010) . As GHB induces absence-like electrophysiological patterns in some mammals, the effects of GHB on thalamocortical projections were extensively studied (Venzi, DI Giovanni, & Crunelli, 2015) . In this context, in vitro studies using cat and rat thalamus have revealed differential presynaptic and postsynaptic effects of GHB on thalamocortical neurons. Postsynaptically, GHB applied to thalamic GABA-A neurons indirectly increased tonic inhibition (Cope et al., 2009) , resulting in decreased cortical activity.
Also presynaptically, GHB-induced activation of GABA-B receptors reduces sensory and thalamocortical excitatory postsynaptic potentials (Emri, Antal, & Crunelli, 1996; Gervasi et al., 2003) . However, GABA-B autoreceptors on GABAergic neurons also have an important function for thalamocortical disinhibition, as GHB reduces somatosensory inhibitory postsynaptic potentials (IPSPs) via this mechanism (Gervasi et al., 2003) , leading to increased cortical activity. Thus, on the thalamic level, GHB seems to work as a differential regulator of cortical activity. Consequently, the observed increase of rAI-thalamic rsFC is most likely generated by GABA-B mediated disinhibition of somatosensory projections, which is the bottom-up element of an overall activation of the salience and reward networks, corresponding to subjective hedonic effects such as euphoria, sexual arousal, and enhanced body and emotion awareness (Bosch et al., 2015; Bosch, Esposito, et al., 2017; .
Another limbic area that was explored in this study is the ACC, a key structure for the mediation of the neuropsychopharmacological effects of GHB. Activation of a salience and reward network including the ACC, vmPFC, and NAcc-presumably due to mesolimbic dopamine disinhibition via the VTA-was shown to be the neural underpinning of GHB-induced prosexual effects . Moreover, GHB increased ACC rCBF, which was the reason to investigate the rsFC of this area in the here presented analysis (Bosch, Esposito, et al., 2017) . In our subjects, we found a reduction of ACC-rsFC to the paracentral lobule. This is was in line with our expectations, as the paracentral lobule is a core hub of the somatosensory network and involved in the processing of body perception (Lavagnino et al., 2014) , pain (Roy, Piche, Chen, Peretz, & Rainville, 2009; Seminowicz & Davis, 2007) , and sexual experience (Moulier et al., 2006) . Interestingly, in healthy subjects the perception of pain was associated with increased activity in the paracentral lobule (Roy et al., 2009 , Seminowicz & Davis, 2007 , whereas on the other hand, GHB reduces pain in patients with fibromyalgia (Russell et al., 2011; Russell, Perkins, Michalek, & Oxybate, 2009; Scharf, Baumann, & Berkowitz, 2003) . Regarding the topography of the somatosensory cortex, the paracentral lobe represents the genitals in females and males (Komisaruk et al., 2011; Narici et al., 1991) . In a study with healthy male volunteers, penile erection evoked by erotic pictures correlated with activation of a canonic sexual arousal network including the paracentral lobule (Moulier et al., 2006) . Both the paracentral lobule and the ACC have important roles in the mediation of sexual cue reactivity, sexual arousal, and physical sexual experience.
Although rsFC increases tend to represent recruitment of brain areas to other areas or networks, rsFC reductions are either interpreted as reduced function or exclusion of a certain area or-in case of top-down structures-a reduction of control and thus a disinhibition of the target area. Latter mechanism seems to explain best the here found ACC-rsFC reduction to the paracentral lobule. Finally, although we found a correlation between ACC activity and sexual arousal in our previous analysis , no such association of ACC-rsFC with the paracentral lobule could be detected here. Most likely, either there is no association of ACC-paracentral lobule-rsFC with sexual arousal, or our study had not enough power to detect it.
In the previous analysis , significant neuronal and prosexual effects were related to active visual stimulation, whereas the here presented analysis focused on the overall and rather intrinsic prosexual effects of GHB, which are less intense. A limitation of our study is that effectivity of blinding was not systematically assessed. Given that we used a dose, whose effects can be subjectively recognized, it is unclear if expectations regarding the GHB effect might have influenced our results. Future studies using GHB should systematically assess effectivity of blinding. Due to informed consent, additional bias may have resulted from the knowledge of the participants that a sexual stimulation task was used in the study.
Another potential limitation of our study is that part of the data had been published previously Bosch, Esposito, et al., 2017; 
| CONCLUSION
In summary, GHB exerts hedonic subjective effects such as euphoria and sexual arousal that are paralleled by increased rsFC of the rAI to the bilateral superior frontal cortex and the right thalamus and decreased rsFC of the ACC to the paracentral lobule. Moreover, increased rAI-rsFC to the bilateral superior frontal cortex correlated with GHB-induced euphoria. Consequently, GHB modulates limbic rsFC with areas that are linked to regulation of mood, cognitive control, and sexual experience, further explaining the drug's unique acute effects at the neuronal level.
